These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1532070)

  • 1. [Can coronary "restenosis" after percutaneous angioplasty be prevented?].
    Juliard JM; Himbert D; Steg PG
    Presse Med; 1992 Feb; 21(4):149-52. PubMed ID: 1532070
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence on early outcome and restenosis of urokinase before elective coronary angioplasty.
    Mehan VK; Meier B; Urban P
    Am J Cardiol; 1993 Jul; 72(1):106-8. PubMed ID: 8517416
    [No Abstract]   [Full Text] [Related]  

  • 3. Restenosis following placement of an intracoronary heparin treated tantulum stent in the hyperlipidemic miniature swine model.
    Jenkins JS; Webel R; Laughlin MH; Rowland SM; Yoklavich MF; Amann JF; Branson K; Myers PR
    J Invasive Cardiol; 1995; 7(6):173-82. PubMed ID: 10155102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From a foggy sight to a clear vision.
    Guagliumi G; Costa M
    JACC Cardiovasc Interv; 2009 May; 2(5):467-9. PubMed ID: 19463472
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticoagulant for primary percutaneous coronary intervention - the last dance for unfractionated heparin?
    Silvain J; Montalescot G
    Arch Cardiovasc Dis; 2012 May; 105(5):259-61. PubMed ID: 22709466
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelets and endothelium: two key players in percutaneous coronary intervention.
    Bonello L; Sabatier F; Camoin-Jau L; Paganelli F; Dignat-George F
    Arch Cardiovasc Dis; 2011 Dec; 104(12):601-3. PubMed ID: 22152511
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjunctive intracoronary dipyridamole in the interventional treatment of small coronary arteries: a prospectively randomized trial.
    Heidland UE; Heintzen MP; Michel CJ; Strauer BE
    Am Heart J; 2000 Jun; 139(6):1039-45. PubMed ID: 10827385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioresorbable Vascular Scaffolds and Very Late Scaffold Thrombosis: Searching an Explanation and a Solution.
    Tanaka A; Latib A; Jabbour RJ; Mitomo S; Regazzoli D; Leone PP; Chieffo A; Carlino M; Montorfano M; Colombo A
    JACC Cardiovasc Interv; 2017 Apr; 10(7):745-746. PubMed ID: 28385416
    [No Abstract]   [Full Text] [Related]  

  • 9. Restenosis after coronary angioplasty.
    Anderson HV; Vignale SJ; Benedict CR; Willerson JT
    J Interv Cardiol; 1993 Sep; 6(3):187-202. PubMed ID: 10151016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin and other potential mechanisms underlying restenosis.
    Wilcox JN
    Circulation; 1991 Jul; 84(1):432-5. PubMed ID: 2060116
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.
    Dangas GD; Caixeta A; Mehran R; Parise H; Lansky AJ; Cristea E; Brodie BR; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Möeckel M; Stone GW;
    Circulation; 2011 Apr; 123(16):1745-56. PubMed ID: 21482968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiology update. Restenosis after coronary angioplasty.
    Smyth D
    Nurs Stand; 1991 Jul 10-16; 5(42):53-4. PubMed ID: 1908281
    [No Abstract]   [Full Text] [Related]  

  • 13. Subacute thrombosis of a bioresorbable vascular scaffold implanted for recurrent in-stent restenosis.
    Rivero F; Benedicto A; Bastante T; Cuesta J; Diego G; Alfonso F
    EuroIntervention; 2015 Nov; 11(7):780. PubMed ID: 25308302
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacologic roles of heparin and glucocorticoids to prevent restenosis after coronary angioplasty.
    Berk BC; Gordon JB; Alexander RW
    J Am Coll Cardiol; 1991 May; 17(6 Suppl B):111B-117B. PubMed ID: 2016469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New directions in antiplatelet therapy.
    Ferreiro JL; Angiolillo DJ
    Circ Cardiovasc Interv; 2012 Jun; 5(3):433-45. PubMed ID: 22715450
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased incidence of stent thrombosis in patients with cocaine use.
    Karlsson G; Rehman J; Kalaria V; Breall JA
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):955-8. PubMed ID: 17492789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very late thrombosis of paclitaxel-eluting stent.
    Aytekin V; Erdim R; Gormez S; Demiroglu C
    Cardiovasc Revasc Med; 2008; 9(4):275-7. PubMed ID: 18928954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin activity during the period of percutaneous coronary revascularization: relation to heparin use, thrombotic complications and restenosis.
    Matthai WH; Kurnik PB; Groh WC; Untereker WJ; Siegel JE
    J Am Coll Cardiol; 1999 Apr; 33(5):1248-56. PubMed ID: 10193724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet therapy after percutaneous coronary intervention.
    Holmes DR
    Cerebrovasc Dis; 2006; 21 Suppl 1():25-34. PubMed ID: 16479099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty.
    Rath B; Bennett DH
    Br Heart J; 1990 Jan; 63(1):18-21. PubMed ID: 2178656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.